Skip to main content

Clene Inc.

For the period ended Dec 31, 2025. Filed Mar 17, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 17, 2026

CLNN$4.41+0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ Equity (Deficit)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(In thousands, except share amounts)

Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’ Equity (Deficit)
Shares · Amount
Balances at December 31, 20236,421,084$1$255,913$(242,723)$199$13,390
Issuance of common stock1,609,222—7,310——7,310
Issuance of equity-classified pre-funded warrants——1,894——1,894
Exercise of stock options41,090—124——124
Exercise of pre-funded warrants17,626—————
Stock-based compensation expense——7,953——7,953
Issuance of common stock upon vesting of restricted stock awards543—————
Unrealized loss on available-for-sale securities————(1)(1)
Foreign currency translation adjustment————(127)(127)
Net loss———(39,400)—(39,400)
Balances at December 31, 20248,089,565$1$273,194$(282,123)$71$(8,857)
Issuance of common stock2,336,115—10,510——10,510
Cashless exercise of pre-funded warrants424,294—————
Stock-based compensation expense——6,382——6,382
Issuance of stock options as payment of bonus liability——445——445
Foreign currency translation adjustment————101101
Net loss———(26,173)—(26,173)
Balances at December 31, 202510,849,974$1$290,531$(308,296)$172$(17,592)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.